Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ARVN | Common Stock | Options Exercise | $240K | +15K | +9.48% | $16.00 | 173K | Dec 17, 2021 | Direct | F1 |
transaction | ARVN | Common Stock | Sale | -$1.05M | -15K | -8.66% | $70.00 | 158K | Dec 17, 2021 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ARVN | Stock Option (right to buy) | Options Exercise | $0 | -15K | -51.05% | $0.00 | 14.4K | Dec 17, 2021 | Common Stock | 15K | $16.00 | Direct | F1, F3 |
Id | Content |
---|---|
F1 | The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2021. |
F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2021. |
F3 | This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested on March 31, 2019, with the remainder of the shares vesting in equal monthly installments following March 31, 2019 through March 31, 2022. |